References
- U.S.A., Food and drug administration. Working to reduce medication errors. 2019. [cited 2024 Jan 25]. Available from: https://www.fda.gov/drugs/information-consumers-and-patients-drugs/working-reduce-medication-errors
- Pannu AK. Methotrexate overdose in clinical practice. Curr Drug Metab. 2019;20:714–719. doi: 10.2174/1389200220666190806140844
- Street RL, Finset A. Two years with COVID-19: New - and old - challenges for health communication research. Patient Educ Couns. 2022;105(2):261–264. doi: 10.1016/J.PEC.2022.01.006
- Vial T, Patat AM, Boels D, et al. Adverse consequences of low-dose methotrexate medication errors: data from French poison control and pharmacovigilance centers. Joint Bone Spine. 2019;86:351–355. doi: 10.1016/J.JBSPIN.2018.09.006
- Reporting and learning systems for medication errors: the role of pharmacovigilance centres n.d. [cited 2024 Jan 25]. Available from: https://www.who.int/publications/i/item/9789241507943
- Morimoto T, Gandhi TK, Seger AC, et al. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004;13:306. doi: 10.1136/QSHC.2004.010611
- Pavkovic S, Grady E, Munier WB White paper series serious safety events: a focus on harm classification: deviation in care as link getting to ZeroTM White Paper Series-Edition No. 2 Contributors 2014.
- Zhou S, Kang H, Yao B, et al. Analyzing medication error reports in clinical settings: an automated pipeline approach. AMIA Annual Symposium Proceedings; Nov 28–Dec 1; Portland, Oregon; Vol. 2018; 2018. p. 1611.
- Howard SC, McCormick J, Pui C-H, et al. Preventing and managing toxicities of high-dose methotrexate. Oncology. 2016;21:1471–1482. doi: 10.1634/THEONCOLOGIST.2015-0164
- Patanè M, Ciriaco M, Chimirri S, et al. Interactions among low dose of methotrexate and drugs used in the treatment of rheumatoid arthritis. Adv Pharmacol Sci. 2013;2013:1–8. doi: 10.1155/2013/313858
- Al-Quteimat OM, Al-Badaineh MA. Methotrexate and trimethoprim-sulphamethoxazole: extremely serious and life-threatening combination. J Clin Pharm Ther. 2013;38:203–205. doi: 10.1111/JCPT.12060
- Lee D, Taylor G, Walker J, et al. The effect of concurrent administration of antacids on prednisolone absorption. Br J Clin Pharmacol. 1979;8:92. doi: 10.1111/J.1365-2125.1979.TB05919.X
- Ghannoum M, Roberts DM, Goldfarb DS, et al. Extracorporeal treatment for methotrexate poisoning: systematic review and recommendations from the EXTRIP workgroup. Clin J Am Soc Nephrol. 2022;17:602–622. doi: 10.2215/CJN.08030621
- Singh A, Handa AC. Medication error- a case report of misadventure with methotrexate - PubMed. JNMA J Nepal Med Assoc. 2018;56(211):711–715. doi: 10.31729/jnma.3538
- Jariwala P, Kumar V, Kothari K, et al. Acute methotrexate toxicity: a fatal condition in two cases of psoriasis. Case Rep Dermatol Med. 2014;2014:1–3. doi: 10.1155/2014/946716
- Thompson JA, Love JS, Hendrickson RG. Methotrexate toxicity from unintentional dosing errors: calls to a poison center and death descriptions. J Am Board Fam Med. 2021;34:1246–1248. doi: 10.3122/JABFM.2021.06.210120
- Sajith M, Pawar A, Bafna V, et al. Serum methotrexate level and side effects of high dose methotrexate infusion in pediatric patients with acute lymphoblastic leukaemia (ALL). Indian J Hematol Blood Transfus. 2020;36:51–58. doi: 10.1007/S12288-019-01144-3